Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKSE · HKD · Healthcare · Drug Manufacturers - Specialty & Generic
HK$5.70 (+1.15%) as of
Key statistics
- Market cap
- 4.77B
- P/E (TTM)
- 13.24
- Forward P/E
- 9.65
- EPS (TTM)
- 0.430
- Dividend yield
- 6.57%
- 52-week range
- 5.400 – 9.500
- Beta
- 0.35
- Revenue (TTM)
- 1.35B
- Profit margin
- 26.64%
- Analyst target
- HK$9.75
- Volume
- 650.00k
About Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals. It operates through Hong Kong, Mainland China, and Overseas segments. The company also offers Chinese medical consultation and treatment services. It markets its products under the Tong Ren Tang brand name. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, the Oceania, North America, and Europe. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Wan Chai, Hong Kong
- Employees
- 763
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.